| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 36.17B | 42.33B | 57.94B | 70.72B | 75.26B |
| Gross Profit | 5.51B | 7.83B | 11.44B | 12.05B | 13.61B |
| EBITDA | 1.14B | 3.56B | 6.77B | 7.12B | 8.03B |
| Net Income | 9.28B | 5.37B | 4.49B | 7.09B | 27.54B |
Balance Sheet | |||||
| Total Assets | 255.16B | 149.94B | 126.61B | 89.08B | 89.87B |
| Cash, Cash Equivalents and Short-Term Investments | 15.29B | 20.83B | 28.06B | 20.72B | 25.77B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 69.49B | 31.70B | 23.94B | 14.54B | 22.44B |
| Stockholders Equity | 184.77B | 117.81B | 102.41B | 74.54B | 67.43B |
Cash Flow | |||||
| Free Cash Flow | 3.39B | -6.03B | 7.22B | 452.31M | -983.37M |
| Operating Cash Flow | 5.30B | -3.73B | 8.16B | 1.24B | -195.28M |
| Investing Cash Flow | 10.49B | 3.59B | 214.06M | -5.52B | 20.02B |
| Financing Cash Flow | -18.44B | -7.51B | -5.39B | -1.74B | -16.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥196.30B | 23.67 | 1.86% | 0.76% | -14.55% | 100.23% | |
67 Neutral | ¥7.65T | -848.53 | -2.51% | 1.31% | 6.68% | -106.55% | |
64 Neutral | ¥31.67B | 25.73 | ― | 3.98% | 4.66% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | ¥14.37B | -28.58 | ― | 1.86% | 11.06% | -804.16% | |
50 Neutral | ¥2.03T | -13.30 | -4.26% | 2.30% | 7.29% | -216.41% | |
47 Neutral | ¥183.86B | -19.15 | ― | ― | -34.08% | -122.57% |